A strong start to earnings season lifted the markets to a higher open with the Dow rising 40 points to 15,265. Nasdaq added 3 points to 3487.
On the upside
CytRx (Nasdaq: CYTR) reported positive results for its aldoxorubicin in treating a model of human brain tumors.
Honda will use Clean Diesel Technologies’ (Nasdaq: CDTI) high performance Mixed Phase Catalyst technology in its 2013 Accord Hybrid and Accord Plug-In Hybrid.
A Seeking Alpha contributor wrote that Linn Energy’s (Nasdaq: LINE) recent stock price drop was a buying opportunity.
On the downside
Amarin (Nasdaq: AMRN) will offer 21.7 million American Depositary Shares.
AmeriGas Partners (NYSE: APU) priced its public offering of 7.5 million common units at the discounted price of $47.60 per unit.
Intuitive Surgical (Nasdaq: ISRG) forecast second quarter earnings and revenue below analyst expectations.
In the broad market, advancing issues outpaced decliners by a margin of nearly 3 to 1 on the NYSE and by more than 5 to 3 on Nasdaq. The broader S&P 500 index rose 4 points to 1645.
